Analysis of related risk factors of colorectal adenomatous polyps

doi:10.3969/j.issn.1006-7795.2021.04.015

Abstract

Abstract: Objective To investigate the risk factors of colorectal adenoma incidence. Methods Data of 662 patients with polypoid lesions admitted at Beijing Friendship Hospital from March 2013 to November 2014 were retrospectively collected, including the basic information such as age, gender, body mass index(BMI), family history, past medical history etc. Totally 140 cases of the patients were pathologically diagnosed as colorectal adenoma and 522 subjects of the patients were enrolled as control group. Combined with the collected data, the risk factors had been analyzed. Results The student t test showed that the age was the risk factor of colorectal adenoma (P<0.05). The chi-square test or Fisher exact test showed that the gender, smoking, drinking and polyp-growing history were correlative factors of colorectal adenoma(P<0.05). The multivariate analysis suggested the age (P<0.001), smoking (P=0.021) and drinking (P=0.022) were independent risk factors of colorectal adenoma. Conclusion The age, cigarette smoking, alcohol intake are independent risk factors of colorectal adenoma. Therefore, we should consider the relevant risk factors of the patients and screen high-risk groups to improve the detection rate of adenoma.

Key words: colorectal adenoma, detection rate, risk factors, screening

CLC Number:

R574

Xing Jie, Ren Junyao, Zhang Qian, Sun Xiujing, Yue Bing, Zhang Yijun, Li Rongxue, Zhu Shengtao, Li Peng, Zhang Shutian. Analysis of related risk factors of colorectal adenomatous polyps[J]. Journal of Capital Medical University, 2021, 42(4): 601-608.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2021.04.015

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2021/V42/I4/601

References

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018,68(6):394-424.
[2] Weitz J, Koch M, Debus J, et al. Colorectal cancer [J]. Lancet, 2005, 365(9454):153-165.
[3] 许岸高,姜泊,钟旭辉,等. 广东地区近 20 年大肠癌临床特征的变化趋势 [J]. 中华医学杂志, 2006, 86(4):272-275.
[4] Courtney R J, Paul C L, Carey M L, et al. A population-based crosssectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients [J]. BMC Cancer, 2013, 13:13.
[5] Zheng S, Chen K, Liu X, et al. Cluster randomization trail of sequence mass screening for colorectal cancer [J]. Dis Colon Rectum, 2003, 46(1):51-58.
[6] 李鹏,王拥军,陈光勇,等.中国早期结直肠癌及癌前病变筛查与诊治共识[J].中国实用内科杂志,2015,35(03):211-227.
[7] Ma E, Sasazuki S,Iwasaki M,et al. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men [J]. Cancer Epidemiol,2010,34 (5):534-541.
[8] Yeoh K G, Ho K Y, Chiu H M, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects [J]. Gut, 2011, 60(9):1236-1241.
[9] Wang H M, Chang T H, Lin F M, et al. A new method for post Genome-Wide Association Study (GWAS) analysis of colorectal cancer in Taiwan [J]. Gene, 2013, 518(1):107-113.
[10] 李娇元, 常江, 朱颖, 等. 基于常见遗传变异和传统风险因素的中国南方汉族人群结直肠癌风险预测模型研究[J]. 中华流行病学杂志, 2015, 36(10):1053-1057.
[11] Gupta S, Jacobs E T, Baron J A, et al. Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis[J]. Gut, 2017, 66(3):446-453.
[12] 黄丹, 朱雄增, 盛伟琪. 2019版《WHO消化系统肿瘤分类》胃肠上皮性肿瘤部分解读[J]. 中华病理学杂志,2020,49 (3): 209-213.
[13] 赵波,钟华戈,吴卫, 等.结直肠癌危险因素的流行病学研究进展[J].结直肠肛门外科,2013,19(3):199-202.
[14] 潘丽,孙国平.结直肠癌根治术后复发危险因素分层分析[J].中华肿瘤防治杂志,2018,25(4):270-274.
[15] 房静远,时永全,陈萦晅,等.中国结直肠癌预防共识意见(2016年,上海)[J].胃肠病学,2016,21(11):668-686.
[16] Kim S E, Shim K N, Jung S A, et al. An association between obesity and the prevalence of colonic adenoma according to age and gender [J]. J Gastroenterol, 2007, 42(8):616-623.
[17] Meester R G S, Mannalithara A, Lansdorp-Vogelaar I, et al. Trends in incidence and stage at diagnosis of colorectal cancer in adults aged 40 through 49 years, 1975-2015 [J]. JAMA, 2019, 321(19):1933-1934.
[18] 陈星宇,孔令斌.结直肠腺瘤性息肉癌变相关因素及机制研究进展[J].中华肿瘤防治杂志,2019,26(5):354-358.
[19] Williams C, DiLeo A, Niv Y, et al. Estrogen receptor beta as target for colorectal cancer prevention [J]. Cancer Lett, 2016, 372(1):48-56.
[20] Terry M B, Neugut A I. Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox [J]. Am J Epidemiol, 1998,147(10): 903-910.
[21] Crockett S D, Nagtegaal I D. Terminology, molecular features, epidemiology, and management of serrated colorectal neoplasia [J]. Gastroenterology, 2019, 157(4):949-966.e4.
[22] Ben Q, Wang L, Liu J, et al. Alcohol drinking and the risk of colorectal adenoma: a dose-response meta-analysis [J]. Eur J Cancer Prev, 2015, 24(4):286-295.
[23] Zhu J Z, Wang Y M, Zhou Q Y, et al. Systematic review with meta-analysis: alcohol consumption and the risk of colorectal adenoma [J]. Aliment Pharmacol Ther, 2014, 40(4):325-337.
[24] 安俊平,刘彬,师艾丽, 等. 结肠息肉的临床病理特征及其与癌变的相关分析[J].中国医师杂志,2017,19(7):1035-1037,1042.
[25] Kim Y, Kim Y, Lee S. An association between colonic adenoma and abdominal obesity: a cross-sectional study [J]. BMC Gastroenterol, 2009, 9:4.
[26] Yamaji Y, Okamoto M, Yoshida H, et al. The effect of body weight reduction on the incidence of colorectal adenoma [J]. Am J Gastroenterol, 2008,103(8):2061-2067.
[27] Jacobs E T, Martínez M E, Alberts D S, et al. Association between body size and colorectal adenoma recurrence [J]. Clin Gastroenterol Hepatol, 2007,5(8):982-990.
[28] 林斌,周学斌.高脂血症与腺瘤性结直肠息肉相关性的临床分析[J].医学理论与实践,2015,28(10):1368-1369.
[29] 尉秀清,文卓夫,郑丰平. 高脂血症与结肠腺瘤的关系[J].临床医学,2008,28(10):55.
[30] Soltani G, Poursheikhani A, Yassi M, et al. Obesity, diabetes and the risk of colorectal adenoma and cancer [J]. BMC Endocr Disord, 2019, 19(1):113.
[31] Lin C C, Huang K W, Luo J C, et al. Hypertension is an important predictor of recurrent colorectal adenoma after screening colonoscopy with adenoma polypectomy [J]. J Chin Med Assoc, 2014,77(10):508-512.
[32] Cross A J, Wooldrage K, Robbins E C, et al. Faecal immunochemical tests (FIT) versus colonoscopy for surveillance after screening and polypectomy: a diagnostic accuracy and cost-effectiveness study [J]. Gut, 2019, 68(9):1642-1652.
[33] Phisalprapa P, Supakankunti S, Chaiyakunapruk N. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand [J]. J Med Econ, 2019, 22(12):1351-1361.
[34] Jahn B, Sroczynski G, Bundo M, et al. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria [J]. BMC Gastroenterol, 2019, 19(1):209.